PETV · PetVivo Holdings, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“The independent auditor’s report accompanying our March 31, 2026, financial statements contain an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. The financial statements have been prepared “assuming that we will continue as a going concern,” which contemplates that we will realize our assets and satisfy our liabilities and commitments in the ordinary course of business. We have suffered recurring losses from operations, and our working capital is insufficient to fund our operations for the next 12 months. These factors raise substantial doubt about our ability to continue as a going concern.”View the 10-K filed Jun 29, 2026
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2012 | FY2013 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.14M | $1.13M | $968.71K | $917.16K | $115.59K | $12.58K | $3588 | — | $1510 | $7124 | $75K | — | — | $0 | — | $0 | — | |
| — | -$359.41K | -$6463 | $15.84K | $9853 | -$228.6K | — | — | — | — | — | — | — | — | — | — | — | |
| $386.86K | $137.68K | $101.82K | $221.04K | $201.15K | $10.7K | $19.71K | $77.94K | — | — | — | — | — | $0 | — | $0 | — | |
| $754.75K | $994.86K | $866.88K | $696.13K | -$85.57K | $1883 | -$16.12K | -$77.94K | $1510 | $7124 | $75K | — | — | $0 | — | $0 | — | |
| 66.11% | 87.84% | 89.49% | 75.9% | -74.03% | 14.97% | -449.33% | — | 100% | 100% | 100% | — | — | — | — | — | — | |
| $1.42M | $1.58M | $1.4M | $996.36K | $474.88K | $98.23K | $12.67K | $200.98K | $118.94K | $167.89K | $168.6K | $4396 | $79.54K | -$157.3K | — | $157.3K | — | |
| $3.07M | $2.64M | $3.4M | $3.41M | $1.35M | $94.98K | $171.51K | $38.35K | — | — | — | — | — | — | — | — | — | |
| $4.33M | $4.82M | $6.69M | $5.02M | $3.15M | $1.77M | $1.82M | $4.25M | $2.17M | $16.23M | $3.16M | $1.2M | $49.19K | -$89.89K | -$30.38K | $59.52K | — | |
| $3216 | $6374 | $8550 | $9803 | $8634 | $50.16K | $543.32K | $638.58K | $642.27K | — | — | — | — | — | — | — | — | |
| $511.46K | $174.59K | $126.85K | $114.43K | $65.15K | $86.71K | $559.54K | $646.92K | $643.39K | $746.85K | $743.63K | — | — | — | — | — | — | |
| $9.82M | $9.05M | $11.49M | $9.43M | $4.97M | $1.96M | $2M | $4.59M | $2.29M | $16.4M | $3.33M | $1.2M | $24.65M | — | — | — | — | |
| -$9.06M | -$8.06M | -$10.62M | -$8.73M | -$5.06M | -$1.96M | -$2.02M | -$4.67M | -$2.29M | -$16.39M | -$3.25M | -$1.2M | -$24.65M | — | — | — | — | |
| -793.88% | -711.3% | -1096.45% | -952.23% | -4374.69% | -15574.72% | -56190.97% | — | -151345.5% | -230062.51% | -4334.91% | — | — | — | — | — | — | |
| -$8.55M | -$7.88M | -$10.49M | -$8.62M | -$4.99M | -$1.87M | -$1.46M | -$4.03M | -$1.64M | -$15.64M | -$2.51M | — | — | — | — | — | — | |
| $12.67K | $6138 | — | — | — | $228.6K | $32.19K | $84.95K | $74.02K | $188.51K | $270.58K | $399.16K | $13.02K | — | — | — | — | |
| $13.1K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$1.41M | -$343.45K | -$333.96K | $15.84K | $41.53K | -$1.56M | -$66.6K | -$84.95K | -$52.02K | -$132.05K | -$1.48M | — | — | $4694 | $3808 | -$886 | — | |
| -$10.47M | -$8.4M | -$10.96M | -$8.72M | -$5.01M | -$3.52M | -$2.08M | -$4.76M | -$2.34M | -$16.52M | -$4.73M | -$1.57M | — | — | — | — | — | |
| -$10.47M | -$8.4M | -$10.96M | -$8.72M | -$5.01M | -$3.52M | -$2.08M | -$4.76M | -$2.34M | -$16.52M | -$4.73M | -$1.57M | -$24.66M | -$452.28K | -$86.21K | -$366.07K | -$263.44K | |
| -917.45% | -741.63% | -1130.92% | -950.5% | -4338.76% | -28007.47% | -58047.21% | — | -154790.6% | -231916.03% | -6307.73% | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | $990.17K | $1.08M | — | — | — | — | — | — | |
| USD/shares | -$0.38 | -$0.41 | -$0.78 | -$0.85 | -$0.57 | -$0.57 | — | — | — | — | — | — | — | $0.00 | — | $0.00 | — |
| USD/shares | -$0.38 | -$0.41 | -$0.78 | -$0.85 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | 30.15M | 20.49M | 13.97M | 10.22M | 8.76M | 6.2M | 5.31M | 4.61M | 4.24M | 2.24M | 1.96M | 1.9M | 94.15M | 28.54M | 30.94M | 24.99M | — |
| shares | 30.15M | 20.49M | 13.97M | 10.22M | — | 6.2M | 5.31M | 4.61M | 4.24M | 2.24M | 1.96M | 1.9M | 94.15M | — | — | — | — |
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 67 similar-size Medical Devices companies (of 145 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Sales to Vedco | $809,161 | $288,929 | $0 | — |
| Sales to Clipper | $40,521 | $194,504 | $0 | — |
| Sales to Convetrus | $0 | $44,015 | $105,637 | — |
| Product | $0 | $430,818 | $626,176 | $636,345 |